| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
|
|
|
|||||||
|
|||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1 Diabetes and Obesity Research Program, Garvan Institute of Medical Research, Sydney, New South Wales, Australia
2 Diabetes and Obesity Research Program, Garvan Institute of Medical Research, 384 Victoria Street, Sydney, New South Wales, 2010, Australia; St Vincent's Hospital Medical School, University of New South Wales, Sydney, New South Wales, Australia
* To whom correspondence should be addressed. E-mail: g.cooney{at}garvan.org.au.
Accumulation of intracellular lipid in obesity is associated with metabolic disease in many tissues including liver. Storage of fatty acid as triglyceride (TG) requires the activation of fatty acids to long chain acyl CoAs by the enzyme acyl CoA synthetase (ACSL). There are five known isoforms of ACSL (ACSL1,3,4,5,6) that vary in their tissue specificity and affinity for fatty acid substrates. To investigate the role of ACSL1 in the regulation of lipid metabolism, we used adenoviral-mediated gene transfer to overexpress ACSL1 in the human hepatoma cell-line HepG2 and in liver of rodents. Infection of HepG2 cells with the adenoviral construct AdACSL1 increased ACSL activity >10-fold compared with controls after 24 hours. HepG2 cells overexpressing ACSL1 had a 40% higher TG content (93±-3 compared to 67±-2 nmol/mg of protein in controls, p<0.05) after 24h exposure to 1mM oleate. Furthermore, ACSL1 overexpression produced a 60% increase in cellular LCACoA content (160±-6 compared to 100±-6 nmol/g of protein in controls, p<0.05), and increased 14C-oleate incorporation into TG without significantly altering fatty acid oxidation. In mice, AdACSL1 administration increased ACSL1 mRNA and protein more than 5-fold over controls at 4 days post infection. ACSL1 overexpression caused a 2-fold increase in TG content in mouse liver (39±4 compared to 20±2 µmicromol/g wet weight in controls, p<0.05) and overexpression in rat liver increased 1-14C palmitate clearance into liver triglyceride. These in vitro and in vivo results suggest a pivotal role for ACSL1 in regulating TG synthesis in liver.
This article has been cited by other articles:
|
|
 |
|
  V. Saraswathi and A. H. Hasty Inhibition of Long-Chain Acyl Coenzyme A Synthetases During Fatty Acid Loading Induces Lipotoxicity in Macrophages Arterioscler Thromb Vasc Biol, November 1, 2009; 29(11): 1937 - 1943. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. O. Li, J. M. Ellis, H. A. Paich, S. Wang, N. Gong, G. Altshuller, R. J. Thresher, T. R. Koves, S. M. Watkins, D. M. Muoio, et al. Liver-specific Loss of Long Chain Acyl-CoA Synthetase-1 Decreases Triacylglycerol Synthesis and {beta}-Oxidation and Alters Phospholipid Fatty Acid Composition J. Biol. Chem., October 9, 2009; 284(41): 27816 - 27826. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Bionaz and J. J. Loor ACSL1, AGPAT6, FABP3, LPIN1, and SLC27A6 Are the Most Abundant Isoforms in Bovine Mammary Tissue and Their Expression Is Affected by Stage of Lactation J. Nutr., June 1, 2008; 138(6): 1019 - 1024. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Zhou, P. Abidi, A. Kim, W. Chen, T.-T. Huang, F. B. Kraemer, and J. Liu Transcriptional Activation of Hepatic ACSL3 and ACSL5 by Oncostatin M Reduces Hypertriglyceridemia Through Enhanced {beta}-Oxidation Arterioscler Thromb Vasc Biol, October 1, 2007; 27(10): 2198 - 2205. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| Visit Other APS Journals Online |
